Hubertus Leonhardt

SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany.

CorCell, Inc. provides umbilical stem cell preservation & cord blood-banking services to use stem cells as future treatments for a variety of diseases and illnesses. The company collects umbilical cord blood stem cells from hospitals in all 50 states and abroad. CorCell has parterships with Maxxim Medical, Kimmel Cancer Center and Independence Blue Cross. CorCell was founded in 1995 and is located in Philadelphia, PA.

SIS Medical AG develops, produces and distributes products for the treatment of vascular diseases. The firm is improving and prolonging human life within the field of minimal invasive therapy. The company was founded by Willi Zwahlen and Michael Schwage and is headquartered in Winterthur, Switzerland.

ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany.

Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.

Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.